A securities class action lawsuit has been filed against Coty Inc. on behalf of investors who purchased stock between Nov. 5, 2025, and Feb. 4, 2026. The lawsuit alleges Coty made misleading statements about the performance of its Consumer Beauty and Prestige fragrance segments. The lead plaintiff deadline for investors to join the lawsuit is May 22, 2026.
Coty Inc. (NYSE: COTY) is facing a securities class action lawsuit filed by The Rosen Law Firm, alleging the beauty company misled investors about its financial performance over a three-month period.
"If you purchased Coty common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement," the law firm stated in a press release. The Rosen Law Firm has a track record of success in securities class actions, having recovered hundreds of millions of dollars for investors.
The lawsuit covers investors who purchased Coty common stock between November 5, 2025, and February 4, 2026. According to the filing, Coty is accused of making false or misleading statements and failing to disclose adverse facts about its business. The allegations center on the true state of Coty's slowing growth, particularly in its Consumer Beauty division, margin compression due to increased marketing investments, and a slowdown in its Prestige fragrance business.
The legal action follows the company's February 5, 2026, second-quarter earnings report, which the lawsuit claims revealed the true market details and resulted in financial damages for investors. The abrupt departure of the company's CEO was also noted in relation to the earnings announcement. The lead plaintiff deadline is May 22, 2026, for investors wishing to take a primary role in the litigation.
This lawsuit places Coty, a major player in the global beauty industry alongside competitors like L'Oréal and Estée Lauder, under increased scrutiny. The outcome of the litigation could have significant financial and reputational implications for the company. Investors will be watching the proceedings closely as the May deadline approaches.
This article is for informational purposes only and does not constitute investment advice.
